Terms ending in 2031
Every in-force patent on Wyeth, LLC's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,980,288 | Emulsion Vaccine Compositions Comprising Antigen and Adjuvant in the Aqueous Phase In force · High confidence | Zoetis Services LLC | In force | High confidence | |
| US 8,409,154 | Method of Delivering a Skin Benefit In force · Medium confidence | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | In force | Medium confidence | |
| US 9,566,186 | Portable Moist Heat System In force · Medium confidence | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | In force | Medium confidence | |
| US 9,644,025 | Immunotherapy Regimes Dependent on Apoe Status In force · High confidence | Janssen Sciences Ireland Uc | In force | High confidence | |
| US 8,524,276 | Oral Formulations and Lipophilic Salts of Methylnaltrexone In force · High confidence | Wyeth, LLC | In force | High confidence | |
| US 8,956,651 | Oral Formulations and Lipophilic Salts of Methylnaltrexone In force · Medium confidence | Wyeth, LLC | In force | Medium confidence | |
| US 9,314,461 | Oral Formulations and Lipophilic Salts of Methylnaltrexone In force · Medium confidence | Wyeth, LLC | In force | Medium confidence | |
| US 10,307,417 | Oral Formulations and Lipophilic Salts of Methylnaltrexone In force · Medium confidence | Wyeth, LLC | In force | Medium confidence | |
| US 10,376,505 | Oral Formulations and Lipophilic Salts of Methylnaltrexone In force · Medium confidence | Wyeth, LLC | In force | Medium confidence | |
| US 10,507,206 | Oral Formulations and Lipophilic Salts of Methylnaltrexone In force · Medium confidence | Wyeth, LLC | In force | Medium confidence | |
| 17 more term ends in 2031 · Pro | |||||
10 of 27 patents shown. Soonest term end first, then patent number.
Pro members see all 27.
22 of these are in force and held by Wyeth, LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.